Evidence map›Paper›PMID 42519016›Full record

ArticleiScience2026

Fe

Hairong Zhao, Chen Yang, Shuangyan Bao, Shuanglong Chen, Qingmo Yang, Yating Gai, Kangliang Lou, Heng Liu, Yang Li, Chenggui Zhang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hairong ZhaoYunnan Provincial Key Laboratory of Entomological Biopharmaceutical, College of Pharmacy, Dali University, Dali 671013, China.
Chen YangYunnan Provincial Key Laboratory of Entomological Biopharmaceutical, College of Pharmacy, Dali University, Dali 671013, China.
Shuangyan BaoYunnan Provincial Key Laboratory of Entomological Biopharmaceutical, College of Pharmacy, Dali University, Dali 671013, China.
Shuanglong ChenDepartment of Breast Surgery, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, China.
Qingmo YangDepartment of Breast Surgery, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, China.
Yating GaiXiamen Research Institute of Food and Drug Quality Inspection, Xiamen 361012, China.
Kangliang LouSchool of Medicine, Xiamen University, Xiamen 361013, China.
Heng LiuYunnan Provincial Key Laboratory of Entomological Biopharmaceutical, College of Pharmacy, Dali University, Dali 671013, China.
Yang LiDepartment of Translational Medicine, Xiamen Institute of Rare Earth Materials, Chinese Academy of Sciences, Xiamen 361024, China.
Chenggui ZhangYunnan Provincial Key Laboratory of Entomological Biopharmaceutical, College of Pharmacy, Dali University, Dali 671013, China.
Ruiqin YangDepartment of Breast Surgery, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditional chemotherapy for breast cancer faces limitations, including poor drug bioavailability, multidrug resistance, and severe systemic side effects. Therefore, a carrier-free nanodrug composed of Mastoparan M (Mast-M, derived from Wasp toxin), FDA-approved near infrared fluorescence dye (indocyanine green, ICG), and biosafe ion Fe

Indexed as

breast cancercarrier-free nanoassemblieschemodynamic therapyindocyanine greenMastoparan Moxidative stress

Identifiers

PMID42519016
PMCPMC13382609

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.